Key result
Single-cell RNA sequencing of murine models identified over 48,000 liver-expressed lncRNAs and revealed significant lncRNA dysregulation and spatial zonation perturbations in NASH and liver fibrosis.
Why the study?
The vast majority of lncRNAs are uncharacterized despite their functional diversity and tissue specificity.
Does high fat diet-induced NASH alter the expression and spatial zonation of long non-coding RNAs in mouse liver cells?
Does high fat diet-induced NASH alter the expression and spatial zonation of long non-coding RNAs in mouse liver cells?
This study provides a comprehensive catalog of mouse liver lncRNAs and identifies specific lncRNAs dysregulated during NASH progression, offering potential novel biomarkers and therapeutic targets.
No immediate clinical implications for NASH or fibrosis; leaves open lncRNA roles in human liver disease.
Summary LncRNAs are typified by low expression, nuclear enrichment, high tissue-specificity and functional diversity, but the vast majority are uncharacterized. Here, we develop a catalog of 48,000 mouse liver-expressed lncRNAs and use to elucidate lncRNA dysregulation in high fat diet-induced non-alcoholic steatohepatitis and carbon tetrachloride-induced liver fibrosis by single cell RNA-seq. LncRNA zonation patterns across the liver lobule were discovered in five cell populations. Perturbations in lncRNA expression were common in disease-associated cell types, including non-alcoholic steatohepatitis-associated macrophages, a hallmark of fatty liver disease progression, and collagen-producing myofibroblasts, key to liver fibrosis. Gene regulatory network analysis linked individual lncRNAs to biological pathways and network centrality metrics identified network-essential, disease-associated regulatory lncRNAs. Regulatory lncRNAs with network-predicted target gene promoters enriched for triplex-based lncRNA binding were also identified. These findings elucidate hepatic lncRNA cell-type specificities, spatial zonation patterns, linked biological networks and dysregulation in disease progression. A subset of the disease-associated lncRNAs have human orthologs and are promising candidates for biomarkers and therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Karri et al. (2022) studied Non-alcoholic steatohepatitis and liver fibrosis. High fat high fructose diet (HFHFD) and Carbon tetrachloride (CCl4) vs. Chow diet / Healthy liver was evaluated on LncRNA transcriptomic dysregulation. Single-cell RNA sequencing of murine models identified over 48,000 liver-expressed lncRNAs and revealed significant lncRNA dysregulation and spatial zonation perturbations in NASH and liver fibrosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: